Neoadjuvant Chemotherapy in Triple Negative Breast Cancer: An Observational Study

Triple negative breast cancer (TNBC) is a phenotype of breast cancer with aggressive clinical behavior. Because of the absence of optimal treatment, the prognosis of this disease is poor. The main purpose of this study was to detect the response to neoadjuvant chemotherapy (NACT) in a TNBC cohort an...

Descripción completa

Detalles Bibliográficos
Autores principales: Shao, Zhiying, Chaudhri, Shalini, Guo, Meng, Zhang, Longzhen, Rea, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cognizant Communication Corporation 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7838690/
https://www.ncbi.nlm.nih.gov/pubmed/27131315
http://dx.doi.org/10.3727/096504016X14562725373879

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7838690/
https://www.ncbi.nlm.nih.gov/pubmed/27131315
http://dx.doi.org/10.3727/096504016X14562725373879

Ejemplares similares